Complex Innovative Designs for Oncology

Complex Innovative Designs for Oncology

ACCELERATING CANCER DRUG DEVELOPMENT THROUGH ADVANCED TRIAL DESIGN

We architect Bayesian adaptive trials, synthetic control arms, and robust safety monitoring frameworks for oncology biotechs and pharmaceutical teams. From first in human dose escalation through NDA submission.

Background Image

Why OncoMetrika

Built for oncology. Built for speed.

We focus exclusively on cancer drug development. Senior biostatisticians working directly with your team. No project managers, no junior analysts learning on your data.

Why OncoMetrika

Built for oncology. Built for speed.

We focus exclusively on cancer drug development. Senior biostatisticians working directly with your team. No project managers, no junior analysts learning on your data.

Icon

100%

100%

Oncology Focused

Icon

Direct

Direct

Senior Expert Access

Icon

Phase I to III

Phase I to III

Cancer Trial Experience

Icon

50% Faster

50% Faster

AI Accelerated Reviews

Icon
Icon
Icon

100%

Oncology Focused

Icon

Direct

Senior Expert Access

Icon

Phase I to III

Cancer Trial Experience

Icon

50% Faster

AI Accelerated Reviews

Icon
Dot Image
Bg Image

Your cancer trial data deserves more than a generalist.

Whether you need a statistical analysis plan for your Phase II solid tumor study or a network meta analysis for your NICE submission, let's talk.

Bg Image

Your cancer trial data deserves more than a generalist.

Whether you need a statistical analysis plan for your Phase II solid tumor study or a network meta analysis for your NICE submission, let's talk.

Bg Image

Your cancer trial data deserves more than a generalist.

Whether you need a statistical analysis plan for your Phase II solid tumor study or a network meta analysis for your NICE submission, let's talk.

Logo

Oncology biostatistics and evidence synthesis for cancer drug development. We help biotech and pharmaceutical teams navigate clinical trials, FDA submissions, and HTA reviews for solid tumors and hematologic malignancies.

Contact us through E-mail

Stay Connected!

Get in touch to see how our experts can help you.

Social Media

LinkedIn

Bg Shape

© 2026 OncoMetrika. All rights reserved.

Nexro

Logo

Oncology biostatistics and evidence synthesis for cancer drug development. We help biotech and pharmaceutical teams navigate clinical trials, FDA submissions, and HTA reviews for solid tumors and hematologic malignancies.

Contact us through E-mail

Stay Connected!

Get in touch to see how our experts can help you.

Bg Shape

© 2026 OncoMetrika. All rights reserved.

Nexro

Logo

Oncology biostatistics and evidence synthesis for cancer drug development. We help biotech and pharmaceutical teams navigate clinical trials, FDA submissions, and HTA reviews for solid tumors and hematologic malignancies.

Contact us through E-mail

Stay Connected!

Get in touch to see how our experts can help you.

Bg Shape

© 2026 OncoMetrika. All rights reserved.

Nexro